Determines GPCR structures plus initial agonists and antagonists in approximately three to six months, depending on the project and resources to be committed
Designs and implements validation and screening strategies
Designs ligands and leads that are highly specific to intended targets, reducing side effects
In partnered programs, provides expert biomedical insight and critical scientific expertise regarding the pathology and molecular pathways of disease
Contact us to discuss moving your program forward.